Breakthrough Drug Extends Pancreatic Cancer Survival | Philadelphia News

FDA just approved daraxonrasib, a game-changing drug for advanced pancreatic cancer, doubling survival time from six to thirteen months in trials — the first treatment ever to extend life for metastatic cases. Patients like April Holmes, once given months to live, now see hope for family moments and travel. Doctors call it a decade-defining breakthrough, with potential to unlock years of extra life as research advances. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/9d7453cfa785e1b7